Lipid-accumulated reactive astrocytes promote disease progression in epilepsy.
Zhang-Peng ChenSuji WangXiansen ZhaoWen FangZhengge WangHaojie YeMeng-Ju WangLing KeTengfei HuangPin LvXiaohong JiangQi-Peng ZhangLiang LiShu-Tao XieJing-Ning ZhuChunhua HangDijun ChenXiangyu LiuChao YanPublished in: Nature neuroscience (2023)
Reactive astrocytes play an important role in neurological diseases, but their molecular and functional phenotypes in epilepsy are unclear. Here, we show that in patients with temporal lobe epilepsy (TLE) and mouse models of epilepsy, excessive lipid accumulation in astrocytes leads to the formation of lipid-accumulated reactive astrocytes (LARAs), a new reactive astrocyte subtype characterized by elevated APOE expression. Genetic knockout of APOE inhibited LARA formation and seizure activities in epileptic mice. Single-nucleus RNA sequencing in TLE patients confirmed the existence of a LARA subpopulation with a distinct molecular signature. Functional studies in epilepsy mouse models and human brain slices showed that LARAs promote neuronal hyperactivity and disease progression. Targeting LARAs by intervention with lipid transport and metabolism could thus provide new therapeutic options for drug-resistant TLE.
Keyphrases
- temporal lobe epilepsy
- drug resistant
- mouse model
- multidrug resistant
- end stage renal disease
- cognitive decline
- acinetobacter baumannii
- randomized controlled trial
- ejection fraction
- fatty acid
- high fat diet
- poor prognosis
- chronic kidney disease
- single cell
- single molecule
- patient reported outcomes
- subarachnoid hemorrhage
- gene expression
- high fat diet induced
- long non coding rna
- body mass index
- drug delivery
- physical activity